A project for research into Prader-Willi syndrome, winner of the Pau Massana Grant

by Instituto de Investigación e Innovación Parc Taulí

1 year ago
Prader-Willi syndrome, Pau Massana Grant

This syndrome is the one that has received the financial donation from Cellers Maset, that through the Pau Massana scholarship collaborates annually with the Parc Taulí Research and Innovation Instit...

Research into treatments to combat obesity and excessive sleepiness in children with Prader-Willi syndrome

by Fundació Sant Joan de Déu

2 years ago
Prader-Willi syndrome, obesity, narcolepsy

Researchers from Sant Joan de Déu have promoted various research projects in recent years to advance the understanding of Prader-Willi syndrome and study new treatments for children affected by this ...

PBF-999, the first in class treatment in development for the Prader-Willi Syndrome has received “Orphan Drug Designation” by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA)

by Palobiofarma

2 years ago
Prader-Willi Syndrome, PBF-99

The Orphan Drug Designation indicates the acknowledgement by the Regulatory Authorities of USA and the EU that PBF-999 have the potential to address the specific needs of individuals suffering from Pr...

Palobiofarma Receives Rare Pediatric Disease Designation from the U.S. FDA for PBF-999 for the Treatment of Prader-Willi Syndrome

by Palobiofarma

3 years ago
Palobiofarma, Rare Pediatric Disease (RPD) Designation, FDA, Prader-Willi Syndrome

Palobiofarma has announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) Designation for the company’s phosphodiesterase 10 (PDE-10) inhibitor, PBF-999, f...